The Global Structural Heart Devices Market size was estimated at USD 15.08 billion in 2021 and is expected to hit around USD 28.85 billion by 2031, poised to grow at a compound annual growth rate (CAGR) of 8.56% from 2022 to 2031.

Global Structural Heart Devices Market: Breakup by Region, 2022 & 2031

Source: Primary Research and Secondary Research Analysis

The market for medical devices used to treat structural defects of the heart with minimally invasive treatments is known as the "Global Structural Heart Devices Market." These devices are used to treat difficult cardiovascular disorders like congenital heart abnormalities, heart valve problems, and other issues that cannot be effectively treated with conventional therapies.

The market includes a wide variety of cutting-edge products, such as delivery systems, occluders, and transcatheter heart valves. Instead of requiring costly surgical procedures like open-heart surgeries, these devices are frequently implanted through tiny incisions or guided through blood arteries, lessening patient risks and shortening recovery periods.

A number of significant developments are influencing different industries across the board in the current global market environment. Businesses are quickly incorporating cutting-edge technology like artificial intelligence (AI), the Internet of Things (IoT), and data analytics to improve operations and consumer experiences as part of the driving force known as digital transformation. A rise in virtual collaboration tools and platforms is a result of the normalisation of remote work.

Consumer tastes and business practises are being more influenced by sustainability and environmental concern. To meet the rising demand for ecologically friendly products, businesses are embracing eco-friendly programmes, sustainable sourcing, and packaging. Models of the circular economy, which emphasise less waste and longer product lifespans, are becoming more popular.

The pandemic-driven rapid uptake of telemedicine and digital health solutions has had a huge impact on healthcare. Telehealth services are boosting access to medical consultations and altering patient-doctor interactions.

As e-commerce keeps growing, businesses are being compelled to improve their online presence and streamline logistics for quick delivery around the world. Retail dynamics have changed as a result of the growth of direct-to-consumer brands and online marketplaces.

Download Free Sample Report

Recent Developments:

Recent noteworthy advances in the global structural heart devices market are changing the face of cardiovascular healthcare. The ongoing development and growth of transcatheter technologies is one important development. The use of mitral valve repair/replacement and transcatheter aortic valve replacement (TAVR) has advanced significantly, allowing for more precise and minimally invasive therapies for patients with complex heart valve problems. These discoveries have sparked partnerships between manufacturers of medical devices, doctors, and researchers, leading to enhanced device designs and therapeutic effects.

Furthermore, treatment planning and patient selection have undergone radical change as a result of the integration of cutting-edge imaging and 3D modelling technology. Clinicians can now tailor therapies using accurate pre-procedural imaging, increasing success rates and lowering complication rates. Patient outcomes and recovery experiences are being improved by this trend towards personalised therapy.

The investigation of structural cardiac procedures for new reasons is another development. These devices, which were initially developed to treat valvular problems, are now being modified to treat conditions like heart failure and congenital heart deformities. This growth is encouraging research into novel therapy strategies and gadget designs, providing patients with new treatment alternatives who previously had few options.

Market Segmentation:

Market Breakup: By Product Type

• Transcatheter Heart Valves
• Occludes
• Annuloplasty Rings
• Others

Market Breakup: By Indication

• Aortic Stenosis
• Mitral Regurgitation
• Congenital Heart Defects
• Others

Market Breakup: By End-User

• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics

Market Breakup: By Technology

• Advanced Imaging Systems
• Robotic-Assisted Procedures
• Navigation Tools

Regional Analysis

The size and scope of the global Structural Heart Devices industry vary by region and are important and expanding. Below is a quick summary of the industry's regional analysis:

North America: The region accounts for a sizeable portion of the worldwide market, particularly the United States and Canada. The market is expanding as a result of sophisticated healthcare infrastructure, well-established reimbursement systems, and a high prevalence of cardiovascular disorders. Expansion has been fuelled by ongoing technology developments and early adoption of novel treatments including transcatheter procedures.

Europe: The healthcare industry is well-developed and the ageing population in European nations like Germany, France, and the United Kingdom are both driving the market's expansion. Patients are safer and innovations are more likely when there are strict regulatory procedures and an emphasis on clinical evidence. European countries are also crucial hubs for joint clinical trials and research projects.

Asia-Pacific: The Asia-Pacific area, which includes nations like China, India, and Japan, is experiencing a significant market expansion as a result of rising heart disease prevalence and a better healthcare system. The use of structural heart implants is being fuelled by expanding healthcare investments, growing awareness of less invasive treatments, and a sizable patient base.

South America: As healthcare costs rise and access to cutting-edge therapies improves, nations like Brazil and Argentina are seeing development in the structural heart devices industry. The region's market is expanding as a result of economic growth and growing public knowledge of minimally invasive procedures.

Middle East & Africa: The market development in the Middle East and Africa region varies. Some nations, such Saudi Arabia and the United Arab Emirates, have sophisticated healthcare systems and are implementing cutting-edge technologies. In contrast, other regions confront difficulties with healthcare infrastructure and affordability, which has an effect on market expansion.

Market Breakup By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Competitive Landscape

The Structural Heart Devices Industry competitive landscape provides details by competitor. Details included are company outline, company financials, revenue generated, market potential, investment in research and development, new market initiatives, worldwide occurrence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The overhead data points providing are only related to the businesses’ focus related to Structural Heart Devices marketplace.

Major players operating in the Global Structural Heart Devices Industry are:

• Edwards Lifesciences Corporation
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• CryoLife, Inc.
• JenaValve Technology, Inc.
• Micro Interventional Devices, Inc.
• Braile Biomédica
• Lepu Medical Technology
• TTK Healthcare Limited
• Xeltis
• NeoChord, Inc.
• Comed BV
• Transseptal Solutions Ltd.

Frequently Asked Questions (FAQs)

Q1) What is meant by Structural Heart Devices?

Ans: Structural heart devices are medical tools for minimally invasive treatment of heart defects, like valves or vessels, to restore normal function.

Q2) Which was the dominant region for the Global Structural Heart Devices Market in 2022?

Ans: North America was the dominant region for the global structural heart devices market in 2022, with a market share of 45.31%.

Q3) What are the challenges in the Global Structural Heart Devices Market?

Ans: Regulatory complexities, limited reimbursement, high costs, technical complexities, and competition with traditional surgical methods are some of the challenges of Global Structural Heart Devices Market.

Q4) What are the major drivers for the Global Structural Heart Devices Market?

Ans: Increasing cardiovascular diseases, aging populations, technological advancements, preference for minimally invasive procedures, and expanding awareness of advanced treatment options are the drivers of Global Structural Heart Devices Market